Page 6 - Haematologica May 2022

Cell Therapy & Immunotherapy
1054 Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study
Hildegard T. Greinix et al.
https://doi.org/10.3324/haematol.2020.265769
Coagulation & its Disorders
1064 A homozygous duplication of the FGG exon 8-intron 8 junction causes congenital afibrinogenemia. Lessons learned from the study of a large consanguineous Turkish family
Michel Guipponi et al.
https://doi.org/10.3324/haematol.2021.278945
Hemostasis
1072 Germline GATA2 variant disrupting endothelial eNOS function and angiogenesis can be restored by c-Jun/AP-1 upregulation Giulio Purgatorio et al.
https://doi.org/10.3324/haematol.2021.278450
Hodgkin Lymphoma
1086 Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study
Andrew M. Evens et al.
https://doi.org/10.3324/haematol.2021.278438
Immunological Dysregulation
1095 Complement dysregulation is associated with severe COVID-19 illness Jia Yu et al.
https://doi.org/10.3324/haematol.2021.279155
Myeloproliferative Disorders
1106 Hemorrhage in patients with polycythemia vera receiving aspirin with an anticoagulant: a prospective, observational study Jeffrey I. Zwicker et al.
https://doi.org/10.3324/haematol.2021.279032
Non-Hodgkin Lymphoma
1111 Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients – a matched control multicenter cohort study
Ron Ram et al.
https://doi.org/10.3324/haematol.2021.278288
1119 Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas Jing Gao et al.
https://doi.org/10.3324/haematol.2021.278743
1131 Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma Sara Napoli et al.
https://doi.org/10.3324/haematol.2020.267096
1144 Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma
Richard J. Lin et al.
https://doi.org/10.3324/haematol.2021.278719
haematologica Journal of the Ferrata Storti Foundation
Haematologica 2022; vol. 107 no. 5 - May 2022 http://www.haematologica.org/